水溶性人参寡糖防止斯科波胺诱导的胆功能障碍和炎症性细胞因子过度表达
Ting Zeng1, Chengwei Zhang2, Lili Sun3
1Department of Rehabilitation Therapeutics, School of Nursing, Jilin University, Changchun, Jilin, China.
Cell biochemistry and biophysics
|January 3, 2025
概括
水溶性人参寡糖 (WGOS) 通过增强胆固醇系统和减少阿尔茨海默病小鼠模型中的神经炎症来改善记忆和认知.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 人参研究研究研究
背景情况:
- 阿尔茨海默氏病 (AD) 的特点是胆固醇缺乏和神经炎症.
- 水溶性人参寡糖 (WGOS) 显示出对抗记忆障碍的保护潜力.
研究的目的:
- 在AD小鼠模型中研究WGOS对胆能功能和神经炎症的影响.
- 阐明WGOS保护作用背后的机制.
主要方法:
- 在使用斯科波胺的小鼠中建立了AD模型.
- 预先用WGOS或盐水对小鼠进行治疗.
- 通过行为测试来评估认知功能.
- 测量了乙胆 (ACh) 度和乙胆酶 (AChE) 活性.
- 使用ELISA量化了炎症性细胞因子 (IL-1β,TNF-α) 的水平.
主要成果:
- 在斯科波拉胺诱导的小鼠中,WGOS治疗显著改善了识别记忆.
- 通过WGOS,预防了斯科波胺诱导的海马ACh水平的下降.
- WGOS抑制了皮胺诱导的海马体ACHE活动的增加.
- WGOS治疗抑制了海马中IL-1β和TNF-α的上调.
结论:
- 通过调节胆能系统和减少神经炎症,WGOS可以改善认知障碍.
- WGOS显示出作为治疗学习和记忆障碍的治疗剂的潜力.
更多相关视频
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
613
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
613
Cholinergic Antagonists: Therapeutic Uses
709
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
709
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
683
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
683
Cholinergic Antagonists: Pharmacokinetics
408
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
408
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K


